Seeking Alpha We believe that Monday's news is very bullish on the long-term outlook for the stock, but that entry at current prices has a high downside risk, at least for the intermediate -term. Both of its anti-cancer drugs ... Keryx Biopharmaceuticals (KERX), a ... 更多 »
TheStreet.com With the American Society of Clinical Oncology conference wrapping up this week in Chicago, some old-name pharmaceutical stocks are getting a boost for their recent progress on cancer-fighting techniques. Two names that Cramer and Urken continue to ... 更多 »
Investorplace.com Click to EnlargeAcorda Pharmaceuticals (ACOR) is a commercial-stage biotech/ pharmaceutical company that develops drugs for neurological conditions, and looking at the chart, the company's stock is doing quite well, at least in the short term. The price ...
生物谷 Teva Pharmaceutical Industries Ltd (NYSE:TEVA) announced today that the Committee for Medicinal Products for Human Use (CHMP) has recommended that a Marketing Authorization may be issued in the ...
Newswire Today (press release) Some of the world's biggest pharmaceutical closure manufacturers are to be found in Asia. ... The core business of LANXESS is the development, manufacturing and marketing of plastics, rubber, intermediates and specialty chemicals. LANXESS is a member ... and more »
EON: Enhanced Online News (press release) AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for many of the world's leading healthcare companies. As an additional value added service to its customers, the ...
The Herald | HeraldOnline.com More than 100 leading life sciences and pharmaceutical companies already rely on NextDocs solutions including Astra Zeneca, McKesson, Sandoz, Sanofi and the National Cancer Center in Japan. ... discovery and analytical studies; a leading consulting ... and more »
